156 related articles for article (PubMed ID: 37572122)
21. Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.
Radnia N; Hajhashemi M; Eftekhar T; Deldar M; Mohajeri T; Sohbati S; Ghanbari Z
J Med Life; 2019; 12(3):271-275. PubMed ID: 31666830
[TBL] [Abstract][Full Text] [Related]
22. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment.
Umachanger JK; Marcussen ML; Bøggild H; Kjærgaard N; Glavind K
Int Urogynecol J; 2020 Sep; 31(9):1813-1819. PubMed ID: 32447418
[TBL] [Abstract][Full Text] [Related]
23. Which factors should be considered in choosing pessary type and size for pelvic organ prolapse patients in a fitting trial?
Ding J; Song XC; Deng M; Zhu L
Int Urogynecol J; 2016 Dec; 27(12):1867-1871. PubMed ID: 27260324
[TBL] [Abstract][Full Text] [Related]
24. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
Manonai J; Sarit-Apirak S; Udomsubpayakul U
Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
[TBL] [Abstract][Full Text] [Related]
25. Adverse events associated with pessary use over one year among women attending a pessary care clinic.
Kakkar A; Reuveni-Salzman A; Bentaleb J; Belzile E; Merovitz L; Larouche M
Int Urogynecol J; 2023 Aug; 34(8):1765-1770. PubMed ID: 36715742
[TBL] [Abstract][Full Text] [Related]
26. Optimal Pessary Care: A Modified Delphi Consensus Study.
Hooper GL; Atnip S; O'Dell K
J Midwifery Womens Health; 2017 Jul; 62(4):452-462. PubMed ID: 28727233
[TBL] [Abstract][Full Text] [Related]
27. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Dislodgment of Vaginal Pessaries in Women With Pelvic Organ Prolapse: A Cohort Study.
Coelho SCA; Giraldo PC; de Castro EB; Brito LGO; Juliato CRT
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e247-e251. PubMed ID: 32487886
[TBL] [Abstract][Full Text] [Related]
29. Moving On: How Many Women Opt for Surgery After Pessary Use for Prolapse?
Patnam R; Sripad AA; Dengler E; Geller EJ; Wu JM
Female Pelvic Med Reconstr Surg; 2020 Jun; 26(6):387-390. PubMed ID: 31335479
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of ring pessaries versus vaginal hysterectomy for advanced pelvic organ prolapse. A cohort study.
Miceli A; Dueñas-Diez JL
Int Urogynecol J; 2019 Dec; 30(12):2161-2169. PubMed ID: 30863947
[TBL] [Abstract][Full Text] [Related]
31. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
[TBL] [Abstract][Full Text] [Related]
32. An Arterial Vaginal Bleed Resulting from Short-Term Pessary Use: A Case Report.
Rieben K; Epp A
J Obstet Gynaecol Can; 2021 Apr; 43(4):503-505. PubMed ID: 33153940
[TBL] [Abstract][Full Text] [Related]
33. Factors Affecting Successfulness of Vaginal Pessary Use for the Treatment of Pelvic Organ Prolapse.
Lekskulchai O; Wanichsetakul P
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S115-20. PubMed ID: 26387398
[TBL] [Abstract][Full Text] [Related]
34. A simplified protocol for pessary management.
Wu V; Farrell SA; Baskett TF; Flowerdew G
Obstet Gynecol; 1997 Dec; 90(6):990-4. PubMed ID: 9397117
[TBL] [Abstract][Full Text] [Related]
35. [Clinical study on silicone pessary in the treatment of pelvic organ prolapse].
Yang JF; Han JS; Zhu FL; Wang YT; Yao Y; Qiao J
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):487-91. PubMed ID: 23141156
[TBL] [Abstract][Full Text] [Related]
36. Levator ani muscle avulsion is a risk factor for expulsion within 1 year of vaginal pessary placed for pelvic organ prolapse.
Cheung RYK; Lee JHS; Lee LL; Chung TKH; Chan SSC
Ultrasound Obstet Gynecol; 2017 Dec; 50(6):776-780. PubMed ID: 28078670
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with long-term pessary use in women with symptomatic pelvic organ prolapse.
Mao M; Xu T; Kang J; Zhang Y; Ai F; Zhou Y; Zhu L
Climacteric; 2019 Oct; 22(5):478-482. PubMed ID: 30897024
[No Abstract] [Full Text] [Related]
38. What Are the Clinical Factors That Are Predictive of Persistent Pessary Use at 12 Months?
Chan MC; Hyakutake M; Yaskina M; Schulz JA
J Obstet Gynaecol Can; 2019 Sep; 41(9):1276-1281. PubMed ID: 30712905
[TBL] [Abstract][Full Text] [Related]
39. Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.
Wolff B; Williams K; Winkler A; Lind L; Shalom D
Int Urogynecol J; 2017 Jul; 28(7):993-997. PubMed ID: 27942793
[TBL] [Abstract][Full Text] [Related]
40. Current trends in pessary management of vaginal prolapse: a multidisciplinary survey of UK practice.
Brown CA; Pradhan A; Pandeva I
Int Urogynecol J; 2021 Apr; 32(4):1015-1022. PubMed ID: 33034677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
